Back to state act
Description
On 20 February 2026, the European Commission committed a total of EUR 225 million (USD 264.7 million) in funding to facilitate the development and clinical testing of next-generation influenza vaccine...
Sign in to see full description
Intervention Details
Intervention Type
Public procurement, nes
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
20 Feb 2026
Revocation date
No revocation date
Implementation level
Supranational
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 3 sectors
Affected Products
Sign in to access 1 products
Threads
See all
This intervention is not part of any Thread yet.